In the aggregate, the identification of altered immune cell profiles, including CD8+ T cells, NK cells, ILCs, γδ T cells, monocytes, and NKT cells, offers valuable insights into the pathogenesis of DM-TB and signifies potential biomarkers for diagnosis, treatment monitoring, and therapeutic intervention. This evidence concerns the gene CD8A and diabetes mellitus.